Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 18, 2023 | IASO Biotherapeutics | $73.9M Series C | — | Efung Capital, Hongcheng Investment, Housen Care Brothers, Nanjing Jiangbei New Area State-owned Asset Management, Shanghai Waigaoqiao Free Trade Zone Group |